Quantcast

Latest Breast biopsy Stories

2014-09-08 08:30:40

Hologic 3D and 2D mammography systems ranked first and second place respectively in annual independent survey of healthcare providers worldwide by KLAS Research BEDFORD, Mass., Sept. 8, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that its 3D mammography system (Hologic Selenia Dimensions 3D Breast Tomosynthesis) was named "Best in KLAS" in the digital mammography category based on the results of an annual independent survey of healthcare executives and...

2014-07-21 12:25:06

With just under 60% of the amount spent in the U.S., European health authorities bought close to 500,000 more biopsy needles for breast cancer treatment and prevention. VANCOUVER, July 21, 2014 /PRNewswire/ - According to breast cancer biopsy market data released by iData Research (www.idataresearch.com), the European health authorities brought almost 500,000 more biopsy needles in 2013. Notably, the U.S. market focuses more on expensive minimally invasive technologies. European...

2014-07-09 16:26:00

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Biopsy Devices : Technology and Global Markets https://www.reportbuyer.com/product/2212013/Biopsy-Devices--Technology-and-Global-Markets.html This report provides an in-depth study of the global biopsy devices methods by device, therapautic segments and geographic markets from 2012 through 2018, with five-year CAGR projections from 2013 through 2018. It focuses on vital display technologies...

2014-06-24 20:21:36

Study using Hologic 3D Mammography systems is the largest to date involving 139 doctors from 13 U.S. academic and community-based sites BEDFORD, Mass., June 24, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) today announced that a groundbreaking study published in the June 25, 2014 issue of the Journal of the American Medical Association (JAMA), found that Hologic's 3D Mammography (breast tomosynthesis) screening technology finds significantly more invasive cancers than a traditional...

2014-06-11 08:29:46

Hologic's low-dose 3D mammography and 3D-guided breast biopsy are highlighted at annual recognition event BEDFORD, Mass., June 11, 2014 /PRNewswire/ -- Hologic, Inc. (NASDAQ: HOLX) announced today that two products from its 3D mammography platform will be showcased at the Premier, Inc. 2014 Breakthroughs Conference and Exhibition in San Antonio, TX. Hologic's C-View software option (low-dose 3D mammography) and Affirm 3D-guided breast biopsy are two of only 16 medical innovations...

2014-06-10 13:39:38

The University of Texas MD Anderson Cancer Center MD Anderson study also highlights surgeon’s influence on patient care, decision-making Needle biopsy, the standard of care radiological procedure for diagnosing breast cancer, is underused with too many patients undergoing the more invasive, excisional biopsy to detect their disease, according to research from The University of Texas MD Anderson Cancer Center. The study, published in the Journal of Clinical Oncology, also finds...

2014-04-29 20:26:27

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: European Markets for Female and Neonatal Diagnostic Devices (Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland,...

2014-04-28 16:30:29

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MediPoint: Biopsy Devices - Global Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_global_analysis_market_forecasts.html MediPoint: Biopsy Devices - Global Analysis and Market Forecasts SummaryCancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient...

2014-04-28 12:31:45

LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MediPoint: Biopsy Devices - APAC Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_apac_analysis_market_forecasts.html MediPoint: Biopsy Devices - APAC Analysis and Market Forecasts SummaryCancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is...

2014-04-22 12:31:49

LONDON, April 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MediPoint: Biopsy Devices - EU Analysis and Market Forecastshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/medipoint_biopsy_devices_eu_analysis_market_forecasts.html MediPoint: Biopsy Devices - EU Analysis and Market Forecasts SummaryCancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related